- Who We Are
- Clinician Employment
- Publications
- Witness to Witness (W2W)
- El Premio Kugel & Zuroweste a la Justicia en la Salud
- Your Voice Matters: Photovoice Project
Interim VIS for Shingles
On September 11, CDC released an interim VIS for shingles
(herpes zoster) vaccine. ACIP has not yet voted on
recommendations for zoster vaccine. The interim VIS is based
primarily on information from the manufacturer's package insert.
The final VIS will be produced after the ACIP recommendations
have been published in MMWR. The final VIS could differ from the
interim version.
Interim VIS for Shingles
On September 11, CDC released an interim VIS for shingles
(herpes zoster) vaccine. ACIP has not yet voted on
recommendations for zoster vaccine. The interim VIS is based
primarily on information from the manufacturer's package insert.
The final VIS will be produced after the ACIP recommendations
have been published in MMWR. The final VIS could differ from the
interim version.
Interim VIS for Shingles
On September 11, CDC released an interim VIS for shingles
(herpes zoster) vaccine. ACIP has not yet voted on
recommendations for zoster vaccine. The interim VIS is based
primarily on information from the manufacturer's package insert.
The final VIS will be produced after the ACIP recommendations
have been published in MMWR. The final VIS could differ from the
interim version.
Interim VIS for Varicella, January 10, 2007
On January 10, CDC released a revised interim VIS for varicella.
It includes changes to reflect the new two-dose schedule for
children and the availability of the measles-mumps-rubella- varicella (MMRV) vaccine. After ACIP publishes these updated recommendations in MMWR, a final varicella VIS will be developed.
Interim VIS for Varicella, January 10, 2007
On January 10, CDC released a revised interim VIS for varicella.
It includes changes to reflect the new two-dose schedule for
children and the availability of the measles-mumps-rubella- varicella (MMRV) vaccine. After ACIP publishes these updated recommendations in MMWR, a final varicella VIS will be developed.
Interim VIS for Varicella, January 10, 2007
On January 10, CDC released a revised interim VIS for varicella.
It includes changes to reflect the new two-dose schedule for
children and the availability of the measles-mumps-rubella- varicella (MMRV) vaccine. After ACIP publishes these updated recommendations in MMWR, a final varicella VIS will be developed.
Interim VIS for Varicella, January 10, 2007
On January 10, CDC released a revised interim VIS for varicella.
It includes changes to reflect the new two-dose schedule for
children and the availability of the measles-mumps-rubella- varicella (MMRV) vaccine. After ACIP publishes these updated recommendations in MMWR, a final varicella VIS will be developed.
